Human vaccination against Q fever; second advisory letter

The Health Council currently sees no reason to expand the target group for Q fever vaccination. The Council remains committed to limited vaccination, i.e. for some groups of patients with cardiovascular disease who are at greater risk of complications from Q fever. This was the Health Council’s recommendation in an advisory report to the Minister of Health, Welfare and Sport that was published on 14 December 2010.

Committee

• Prof. E.J. Ruitenberg, Emeritus professor of immunology, University of Utrecht; Professor of international health, VU, Amsterdam, chairman
• Prof. J.G. Aarnoudse, Professor of obstetrics en gynaecology, University Medical Center Groningen
• M. Augustijn, Ministry of Agriculture, Nature and Food Quality, The Hague, observer
• Prof. C. Boog, Professor of infectious diseases & immunology, University of Utrecht, Nederlands Vaccin Instituut, Bilthoven
• Prof. W.J.H.M. van den Bosch, Professor of healthcare innovation, University Medical Center St. Radboud, Nijmegen
• Prof. A. Brand, Professor of transfusion medicine, Leiden University Medical Centrum
• Prof. E. Hak, Professor of clinical pharmacoepidemiology, University Medical Center Groningen
• Prof. J.A.P. Heesterbeek, Professor of theoretical epidemiology, University of Utrecht
• W. van der Hoek, Physician-epidemiologist, Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven
• Dr H. Houweling, Physician-epidemiologist, Health Council of the Netherlands, The Hague, adviser
• M.M. Kraaij-Dirkzwager, Ministry of Health, Welfare and Sport, The Hague, observer
• Prof. J.W.M. van der Meer, Professor of internal medicine, University Medical Center St. Radboud, Nijmegen
• Dr J.H. Ovelgönne, Medicines Evaluation Board, The Hague, adviser
• Dr P. Schneeberger, Medical microbiologist, Jeroen Bosch hospital, Den Bosch
• Prof. H.A. Verbrugh, Professor of medical microbiology, Erasmus MC, Rotterdam
• Dr M.F. Verweij, Ethicist, Ethics Institute, University Utrecht
• Prof. H.L. Zaaijer, Clinical microbiologist, Academic Medical Center, Sanquin Blood Supply Foundation, Amsterdam, adviser
• F.G. van Zijderveld, Bacteriology, Central Veterinary Institute, Wageningen
• Dr K. Groeneveld, Medical immunologist, Health Council of the Netherlands, The Hague, scientific secretary
• Dr R. van Houdt, Molecular epidemiologist, Health Council of the Netherlands, The Hague, scientific secretary

Geraadpleegde deskundigen

• Prof. J.P.M. van Putten, Professor of Infection Biology, University Utrecht